Arterys
AI-powered medical imaging platform for improved diagnostics.

What is Arterys?
Arterys is a cloud-based medical imaging platform that leverages artificial intelligence (AI) to enhance diagnostic processes and improve patient outcomes. It offers advanced imaging solutions for various medical fields, including cardiology, oncology, and pulmonary care, enabling healthcare professionals to analyze images more efficiently and accurately. Arterys aims to streamline the diagnostic workflow by integrating AI directly into existing clinical practices.
Key Features:
-
AI-Powered Imaging Solutions: Arterys utilizes AI to assist radiologists in analyzing medical images, providing automated insights that help in diagnosing conditions like lung nodules and heart defects.
-
Cloud-Based Accessibility: The platform is fully web-based, allowing healthcare providers to access imaging data from anywhere, which improves collaboration and speeds up the decision-making process.
-
Real-Time Collaboration: Arterys supports real-time collaboration between healthcare teams, enabling multiple providers to review and analyze images simultaneously.
-
Regulatory Approval: Arterys has received several FDA clearances for its AI solutions, ensuring that its technology meets stringent safety and efficacy standards.
-
Comprehensive Reporting Tools: The platform includes advanced reporting features that assist clinicians in documenting findings and sharing insights with patients and other healthcare providers.
Summary:
Arterys offers a cutting-edge solution for medical imaging that leverages AI to enhance diagnostic accuracy and efficiency. Its cloud-based platform supports real-time collaboration and seamless integration into existing healthcare workflows, making it an invaluable tool for modern radiology and patient care.
Similar Listings

BenevolentAI
Biotechnology company using AI for drug discovery and development to create treatments for diseases.

Cleveland Diagnostics
Develops non-invasive diagnostic tests for early detection of cancers, including prostate cancer.